{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:26:11Z","timestamp":1793834771585,"version":"4.6.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1038\/s41440-026-02786-3","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:27:49Z","timestamp":1787909269000},"page":"3010-3021","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recombinant zoster vaccine and risk of kidney failure, cardiovascular, and mortality in patients with chronic kidney disease"],"prefix":"10.1038","volume":"49","author":[{"given":"Chung-An","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Wei","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Yi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7935-0991","authenticated-orcid":false,"given":"Vin-Cent","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"2786_CR1","unstructured":"CDC: Centers for Disease Control and Prevention. Shingles (Herpes Zoster): Data and Surveillance. 2024. https:\/\/www.cdc.gov\/shingles\/data-research\/index.html. Accessed May 17."},{"key":"2786_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jinf.2017.06.010","volume":"75","author":"C Schr\u00f6der","year":"2017","unstructured":"Schr\u00f6der C, Enders D, Schink T, Riedel O. Incidence of herpes zoster amongst adults varies by severity of immunosuppression. J Infect. 2017;75:207\u201315.","journal-title":"J Infect"},{"key":"2786_CR3","doi-asserted-by":"crossref","unstructured":"Kennedy PGE. The spectrum of neurological manifestations of varicella-zoster virus reactivation. Viruses. 2023;15:1663.","DOI":"10.3390\/v15081663"},{"key":"2786_CR4","doi-asserted-by":"publisher","first-page":"e027451","DOI":"10.1161\/JAHA.122.027451","volume":"11","author":"SG Curhan","year":"2022","unstructured":"Curhan SG, Kawai K, Yawn B, Rexrode KM, Rimm EB, Curhan GC. Herpes zoster and long-term risk of cardiovascular disease. J Am Heart Assoc. 2022;11:e027451.","journal-title":"J Am Heart Assoc"},{"key":"2786_CR5","doi-asserted-by":"publisher","first-page":"e0181565","DOI":"10.1371\/journal.pone.0181565","volume":"12","author":"N Erskine","year":"2017","unstructured":"Erskine N, Tran H, Levin L, Ulbricht C, Fingeroth J, Kiefe C, et al. A systematic review and meta-analysis on herpes zoster and the risk of cardiac and cerebrovascular events. PLOS One. 2017;12:e0181565.","journal-title":"PLOS One"},{"key":"2786_CR6","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10157-018-1641-8","volume":"23","author":"J Ishigami","year":"2019","unstructured":"Ishigami J, Matsushita K. Clinical epidemiology of infectious disease among patients with chronic kidney disease. Clin Exp Nephrol. 2019;23:437\u201347.","journal-title":"Clin Exp Nephrol"},{"key":"2786_CR7","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1053\/j.ajkd.2012.03.018","volume":"60","author":"M-Y Wu","year":"2012","unstructured":"Wu M-Y, Hsu Y-H, Su C-L, Lin Y-F, Lin H-W. Risk of herpes zoster in CKD: a matched-cohort study based on administrative data. Am J Kidney Dis. 2012;60:548\u201352.","journal-title":"Am J Kidney Dis"},{"key":"2786_CR8","doi-asserted-by":"crossref","unstructured":"Marra F, Parhar K, Huang B, Vadlamudi N. Risk factors for herpes zoster infection: a meta-analysis. Open Forum Infect Dis. 2020;7:ofaa005.","DOI":"10.1093\/ofid\/ofaa005"},{"key":"2786_CR9","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1007\/s10096-014-2143-6","volume":"33","author":"SY Lin","year":"2014","unstructured":"Lin SY, Liu JH, Yeh HC, Lin CL, Tsai IJ, Chen PC, et al. Association between herpes zoster and end stage renal disease entrance in chronic kidney disease patients: a population-based cohort study. Eur J Clin Microbiol Infect Dis. 2014;33:1809\u201315.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2786_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000339004","volume":"36","author":"SY Lin","year":"2012","unstructured":"Lin SY, Liu JH, Lin CL, Tsai IJ, Chen PC, Chung CJ, et al. A comparison of herpes zoster incidence across the spectrum of chronic kidney disease, dialysis and transplantation. Am J Nephrol. 2012;36:27\u201333.","journal-title":"Am J Nephrol"},{"key":"2786_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/nep.13741","volume":"26","author":"BM Ma","year":"2021","unstructured":"Ma BM, Yap DYH, Yip TPS, Hung IFN, Tang SCW, Chan TM. Vaccination in patients with chronic kidney disease\u2014review of current recommendations and recent advances. Nephrology. 2021;26:5\u201311.","journal-title":"Nephrology"},{"key":"2786_CR12","doi-asserted-by":"publisher","first-page":"e0313889","DOI":"10.1371\/journal.pone.0313889","volume":"19","author":"F Marra","year":"2024","unstructured":"Marra F, Yip M, Cragg JJ, Vadlamudi NK. Systematic review and meta-analysis of recombinant herpes zoster vaccine in immunocompromised populations. PLoS One. 2024;19:e0313889.","journal-title":"PLoS One"},{"key":"2786_CR13","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","volume":"372","author":"H Lal","year":"2015","unstructured":"Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015;372:2087\u201396.","journal-title":"N Engl J Med"},{"key":"2786_CR14","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.36849\/JDD.7415","volume":"22","author":"MF Helm","year":"2023","unstructured":"Helm MF, Khoury PA, Pakchanian H, Raiker R, Maczuga S, Foulke GT. Recombinant zoster vaccine reduces 3-year cardiovascular risk: insights from a multi-centered database. J Drugs Dermatol. 2023;22:1178\u201382.","journal-title":"J Drugs Dermatol"},{"key":"2786_CR15","doi-asserted-by":"publisher","first-page":"e090428","DOI":"10.1136\/bmjopen-2024-090428","volume":"15","author":"E Kornelius","year":"2025","unstructured":"Kornelius E, Lo S-C, Huang C-N, Wang C-C, Wang Y-H, Yang Y-S. Association of herpes zoster vaccination and cardiovascular risk in patients with diabetes: long-term insights from a retrospective cohort study. BMJ Open. 2025;15:e090428.","journal-title":"BMJ Open"},{"key":"2786_CR16","doi-asserted-by":"publisher","first-page":"e2350050-e","DOI":"10.1001\/jamanetworkopen.2023.50050","volume":"7","author":"H-C Pan","year":"2024","unstructured":"Pan H-C, Chen J-Y, Chen H-Y, Yeh F-Y, Huang TT-M, Sun C-Y, et al. Sodium-glucose cotransport protein 2 inhibitors in patients with type 2 diabetes and acute kidney disease. JAMA Netw Open. 2024;7:e2350050-e.","journal-title":"JAMA Netw Open"},{"key":"2786_CR17","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.jmii.2023.09.005","volume":"56","author":"VC Wu","year":"2023","unstructured":"Wu VC, Chen JY, Lin YH, Wang CY, Lai CC. Assessing the cardiovascular events and clinical outcomes of COVID-19 on patients with primary aldosteronism. J Microbiol Immunol Infect. 2023;56:1158\u201368.","journal-title":"J Microbiol Immunol Infect"},{"key":"2786_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50199-y","volume":"15","author":"HC Pan","year":"2024","unstructured":"Pan HC, Chen JY, Chen HY, Yeh FY, Sun CY, Huang TT, et al. GLP-1 receptor agonists\u2019 impact on cardio-renal outcomes and mortality in T2D with acute kidney disease. Nat Commun. 2024;15:5912.","journal-title":"Nat Commun"},{"key":"2786_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12933-024-02424-7","volume":"23","author":"CA Wang","year":"2024","unstructured":"Wang CA, Lin LC, Chen JY, Wang WJ, Wu VC. Exploring the mortality and cardiovascular outcomes with SGLT-2 inhibitors in patients with T2DM at dialysis commencement: a health global federated network analysis. Cardiovasc Diabetol. 2024;23:327.","journal-title":"Cardiovasc Diabetol"},{"key":"2786_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54171-8","volume":"15","author":"JY Sheu","year":"2024","unstructured":"Sheu JY, Chang LY, Chen JY, Pan HC, Tseng CS, Chueh JS, et al. The outcomes of SGLT-2 inhibitor utilization in diabetic kidney transplant recipients. Nat Commun. 2024;15:10043.","journal-title":"Nat Commun"},{"key":"2786_CR21","doi-asserted-by":"publisher","unstructured":"Chang LY, Liao HW, Chen JY, Wu VC. Enhanced outcomes in type 2 diabetes patients with acute kidney disease through thiazolidinedione. J Clin Endocrinol Metab. 2024. https:\/\/doi.org\/10.1210\/clinem\/dgae796.","DOI":"10.1210\/clinem\/dgae796"},{"key":"2786_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12933-025-02649-0","volume":"24","author":"LC Lin","year":"2025","unstructured":"Lin LC, Chen JY, Huang TT, Wu VC. Association of glucagon-like peptide-1 receptor agonists with cardiovascular and kidney outcomes in type 2 diabetic kidney transplant recipients. Cardiovasc Diabetol. 2025;24:87.","journal-title":"Cardiovasc Diabetol"},{"key":"2786_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-64640-3","volume":"16","author":"CA Wang","year":"2025","unstructured":"Wang CA, Lai HW, Chen JY, Wang WJ, Lin LC, Chiu YL, et al. Finerenone versus spironolactone in patients with chronic kidney disease and type 2 diabetes: a target trial emulation. Nat Commun. 2025;16:9641.","journal-title":"Nat Commun"},{"key":"2786_CR24","doi-asserted-by":"publisher","first-page":"e2427258-e","DOI":"10.1001\/jamanetworkopen.2024.27258","volume":"7","author":"M-H Chuang","year":"2024","unstructured":"Chuang M-H, Chen J-Y, Wang H-Y, Jiang Z-H, Wu V-C. Clinical outcomes of tirzepatide or GLP-1 receptor agonists in individuals with type 2 diabetes. JAMA Netw Open. 2024;7:e2427258-e.","journal-title":"JAMA Netw Open"},{"key":"2786_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02364-2","volume":"23","author":"H-W Lai","year":"2024","unstructured":"Lai H-W, See CY, Chen J-Y, Wu V-C. Mortality and cardiovascular events in diabetes mellitus patients at dialysis initiation treated with glucagon-like peptide-1 receptor agonists. Cardiovasc Diabetol. 2024;23:277.","journal-title":"Cardiovasc Diabetol"},{"key":"2786_CR26","doi-asserted-by":"crossref","unstructured":"Andrade C. Mean difference, standardized mean difference (SMD), and their use in meta-analysis: as simple as it gets. J Clin Psychiatry. 2020;81:20f13681.","DOI":"10.4088\/JCP.20f13681"},{"key":"2786_CR27","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.jchf.2020.07.005","volume":"8","author":"C Perego","year":"2020","unstructured":"Perego C, Sbolli M, Specchia C, Fiuzat M, McCaw ZR, Metra M, et al. Utility of restricted mean survival time analysis for heart failure clinical trial evaluation and interpretation. JACC Heart Fail. 2020;8:973\u201383.","journal-title":"JACC Heart Fail"},{"key":"2786_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3934901","volume":"2022","author":"Q Huang","year":"2022","unstructured":"Huang Q, Tian C. Visualizing time-varying effect in survival analysis: 5 complementary plots to Kaplan-Meier curve. Oxid Med Cell Longev. 2022;2022:3934901.","journal-title":"Oxid Med Cell Longev"},{"key":"2786_CR29","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","volume":"167","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med. 2017;167:268\u201374.","journal-title":"Ann Intern Med"},{"key":"2786_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29667","volume":"96","author":"E Kornelius","year":"2024","unstructured":"Kornelius E, Lo SC, Huang CN, Wang CC, Wang YH, Yang YS. Assessing herpes zoster vaccine efficacy in patients with diabetes: a community-based cohort study. J Med Virol. 2024;96:e29667.","journal-title":"J Med Virol"},{"key":"2786_CR31","doi-asserted-by":"publisher","unstructured":"Eyting M, Xie M, Michalik F, He\u00df S, Chung S, Geldsetzer P. A natural experiment on the effect of herpes zoster vaccination on dementia. Nature. 2025; https:\/\/doi.org\/10.1038\/s41586-025-08800-x.","DOI":"10.1038\/s41586-025-08800-x"},{"key":"2786_CR32","doi-asserted-by":"publisher","unstructured":"Pomirchy M, Bommer C, Pradella F, Michalik F, Peters R, Geldsetzer P. Herpes zoster vaccination and dementia occurrence. JAMA. 2025; https:\/\/doi.org\/10.1001\/jama.2025.5013.","DOI":"10.1001\/jama.2025.5013"},{"key":"2786_CR33","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1192\/bjp.2024.97","volume":"225","author":"AN de Cates","year":"2024","unstructured":"de Cates AN, Harmer CJ, Harrison PJ, Cowen PJ, Emmanuel A, Travis S, et al. Association between a selective 5-HT(4) receptor agonist and incidence of major depressive disorder: emulated target trial. Br J Psychiatry. 2024;225:371\u20138.","journal-title":"Br J Psychiatry"},{"key":"2786_CR34","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1056\/NEJMoa042271","volume":"352","author":"HQ Nguyen","year":"2005","unstructured":"Nguyen HQ, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med. 2005;352:450\u20138.","journal-title":"N Engl J Med"},{"key":"2786_CR35","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/jmv.23892","volume":"86","author":"P-y Wu","year":"2014","unstructured":"Wu P-y, Lin C-L, Sung F-C, Chou T-C, Lee Y-T. Increased risk of cardiovascular events in patients with herpes zoster: a population-based study. J Med Virol. 2014;86:772\u20137.","journal-title":"J Med Virol"},{"key":"2786_CR36","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jacc.2017.05.015","volume":"70","author":"M-C Kim","year":"2017","unstructured":"Kim M-C, Yun S-C, Lee H-B, Lee PH, Lee S-W, Choi S-H, et al. Herpes zoster increases the risk of stroke and myocardial infarction. JACC. 2017;70:295\u20136.","journal-title":"JACC"},{"key":"2786_CR37","volume":"74","author":"SW Lai","year":"2020","unstructured":"Lai SW, Kuo YH, Lin CL, Liao KF. Risk of herpes zoster among patients with predialysis chronic kidney disease in a cohort study in Taiwan. Int J Clin Pr. 2020;74:e13566.","journal-title":"Int J Clin Pr"},{"key":"2786_CR38","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.ekir.2021.02.024","volume":"6","author":"MA Hamad","year":"2021","unstructured":"Hamad MA, Allam H, Sulaiman A, Murali K, Cheikh Hassan HI. Systematic review and meta-analysis of herpes zoster vaccine in patients with CKD. Kidney Int Rep. 2021;6:1254\u201364.","journal-title":"Kidney Int Rep"},{"key":"2786_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.virol.2018.06.013","volume":"522","author":"CN Como","year":"2018","unstructured":"Como CN, Pearce CM, Cohrs RJ, Baird NL. Interleukin-6 and type 1 interferons inhibit varicella zoster virus replication in human neurons. Virology. 2018;522:13\u20138.","journal-title":"Virology"},{"key":"2786_CR40","doi-asserted-by":"crossref","unstructured":"Jarosinski KW, Carpenter JE, Buckingham EM, Jackson W, Knudtson K, Moffat JF, et al. Cellular stress response to varicella-zoster virus infection of human skin includes highly elevated interleukin-6 expression. Open Forum Infect Dis. 2018;5:ofy118.","DOI":"10.1093\/ofid\/ofy118"},{"key":"2786_CR41","doi-asserted-by":"publisher","first-page":"368","DOI":"10.4103\/0971-4065.181477","volume":"26","author":"D Arora","year":"2016","unstructured":"Arora D, Jairam A, Mahapatra D. Renal infarct following varicella infection. Indian J Nephrol. 2016;26:368\u20139.","journal-title":"Indian J Nephrol"},{"key":"2786_CR42","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S1474-4422(09)70134-6","volume":"8","author":"D Gilden","year":"2009","unstructured":"Gilden D, Cohrs RJ, Mahalingam R, Nagel MA. Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol. 2009;8:731\u201340.","journal-title":"Lancet Neurol"},{"key":"2786_CR43","doi-asserted-by":"publisher","first-page":"e1013759","DOI":"10.1371\/journal.ppat.1013759","volume":"21","author":"MJ Johnson","year":"2025","unstructured":"Johnson MJ, Crotteau M, Ghosh D, Vu T, Trinity L, Marches R, et al. The recombinant zoster vaccine induces trained immunity in monocytes through persistent downregulation of TGF\u03b2. PLOS Pathog. 2025;21:e1013759.","journal-title":"PLOS Pathog"},{"key":"2786_CR44","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.vaccine.2023.12.010","volume":"42","author":"CL Smith","year":"2024","unstructured":"Smith CL, Richardson B, Rubsamen M, Cameron MJ, Cameron CM, Canaday DH. Adjuvant AS01 activates human monocytes for costimulation and systemic inflammation. Vaccine. 2024;42:229\u201338.","journal-title":"Vaccine"},{"key":"2786_CR45","doi-asserted-by":"publisher","first-page":"0075_5167","DOI":"10.4049\/jimmunol.212.supp.0075.5167","volume":"212","author":"M Johnson","year":"2024","unstructured":"Johnson M, Crotteau M, Ghosh D, Levin M, Weinberg A. Trained immunity generated by the Recombinant Zoster Vaccine (RZV). J Immunol. 2024;212:0075_5167\u20130075_5167.","journal-title":"J Immunol"},{"key":"2786_CR46","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1001\/jamapediatrics.2021.4251","volume":"176","author":"MB DeSilva","year":"2022","unstructured":"DeSilva MB, Haapala J, Vazquez-Benitez G, Daley MF, Nordin JD, Klein NP, et al. Association of the COVID-19 pandemic with routine childhood vaccination rates and proportion up to date with vaccinations across 8 US Health Systems in the Vaccine Safety Datalink. JAMA Pediatr. 2022;176:68\u201377.","journal-title":"JAMA Pediatr"},{"key":"2786_CR47","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/cid\/civ930","volume":"62","author":"HF Tseng","year":"2016","unstructured":"Tseng HF, Luo Y, Shi J, Sy LS, Tartof SY, Sim JJ, et al. Effectiveness of herpes zoster vaccine in patients 60 years and older with end-stage renal disease. Clin Infect Dis. 2016;62:462\u20137.","journal-title":"Clin Infect Dis"},{"key":"2786_CR48","doi-asserted-by":"publisher","first-page":"6262","DOI":"10.1016\/j.vaccine.2019.09.028","volume":"37","author":"DO Willer","year":"2019","unstructured":"Willer DO, Oostvogels L, Cunningham AL, Gervais P, Gorfinkel I, Hyung Kim J, et al. Efficacy of the adjuvanted recombinant zoster vaccine (RZV) by sex, geographic region, and geographic ancestry\/ethnicity: a post-hoc analysis of the ZOE-50 and ZOE-70 randomized trials. Vaccine. 2019;37:6262\u20137.","journal-title":"Vaccine"},{"key":"2786_CR49","doi-asserted-by":"publisher","first-page":"e076321","DOI":"10.1136\/bmj-2023-076321","volume":"383","author":"NP Klein","year":"2023","unstructured":"Klein NP, Bartlett J, Fireman B, Marks MA, Hansen J, Lewis E, et al. Effectiveness of the live zoster vaccine during the 10 years following vaccination: real world cohort study using electronic health records. BMJ. 2023;383:e076321.","journal-title":"BMJ"},{"key":"2786_CR50","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/infdis\/171.3.701","volume":"171","author":"K Schmader","year":"1995","unstructured":"Schmader K, George LK, Burchett BM, Pieper CF, Hamilton JD. Racial differences in the occurrence of herpes zoster. J Infect Dis. 1995;171:701\u20134.","journal-title":"J Infect Dis"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02786-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02786-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02786-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:04:37Z","timestamp":1793833477000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02786-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["2786"],"URL":"https:\/\/doi.org\/10.1038\/s41440-026-02786-3","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"23 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}